Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Wold Dyan Z.VP, Controller and CAO | Tax withholding | F | $487 5 sh | Jan 16, 2026 |
| 5 | Yates Daniel S.SVP, Chief Accounting Officer | Tax withholding | F | $18K 459 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Tariq MusaDirector | Option exercise | M | — 250 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 5 | Sedgwick Karen LExecutive VP and CFO | Tax withholding | F | $568 6 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $383K 9,258 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $286K 7,046 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $479K 11.5K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $448K 10.7K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Ruttenberg David W.Director | Open-market sale · 10b5-1 plan | SELL | $145K 12.5K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $533K 13.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $348K 8,467 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 3 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 2,813 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 3 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | Grant or award · 10b5-1 plan | A | — 37.2K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 2 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $68K 14.6K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 2 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $93K 5,893 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 1 | Peer AndrewVP, Corporate Controller & CAO | Open-market sale · 10b5-1 plan | SELL | $15K 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Peer AndrewVP, Corporate Controller & CAO | Option exercise · 10b5-1 plan | M | $4,270 1,750 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 62.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Grant or award · 10b5-1 plan | A | — 300.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Grant or award · 10b5-1 plan | A | — 44.7K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 14.6K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Burroughs Amy L.Director, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 27.1K sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $2,446 321 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Inukonda RaviCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | — 1,017 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | — 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $25K 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 62.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 5,893 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 2,678 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 0 | Inukonda RaviCHIEF FINANCIAL OFFICER | Option exercise · 10b5-1 plan | M | $7,790 1,017 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Field DylanDirector, President & CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $94K 2,678 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | D'Amico AndrewDirector | Option exercise · 10b5-1 plan | M | $20K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | — 1,407 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise · 10b5-1 plan | M | $28K 2,813 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 16, 2026 traded Jan 14, 2026 |